New Advance in Breast Cancer
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: closed (30 September 2021) | Viewed by 3414
Special Issue Editor
Interests: breast cancer; estrogen receptor; progesterone receptor; cell signaling; arginine methylation; arginine demethylation; post translational modifications; transcriptional regulation
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Breast cancer is the second most common cancer and the fifth deadliest in the world, still representing a major health challenge. Even if targets have largely improved patient survival, development of resistance has led to the identification of drivers of this phenomena, however, new targeted therapies are being developed in order to offer more therapeutic options, and to circumvent the problem of resistance.
This Special Issue “New Advances in Breast Cancer” will provide an updated overview covering molecular mechanisms and all aspects of targeted therapies in breast cancer, from the basic science to the clinical trials. This Special Issue “New Advances in Breast Cancer” will provide an updated overview covering all aspects of targeted therapies in breast cancer, from the basic science to the clinical trials. There will be a special focus on new promising drugs as well as on potential biomarkers that are predictive for a therapeutic response.
Dr. Muriel Le Romancer
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- breast cancer
- steroid receptors
- cell signaling
- protein kinases
- targeted therapy
- resistance
- biomarkers
